N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
|
|
|
- CAS-Nr.
- 1334513-02-8
- Englisch Name:
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
- Synonyma:
- SF-1.2;ATP-FTP-phoph;Sofosbuvir imp-75;Sofosbuvir-003-SS;SofosBuvir Impurity 15;Sofosbuvir InterMediates;Sofibuvir intermediate 1;Sofosbuvir Intermediate 5;Sofosbuvir side chain N-1;Sofosbuvir InterMediates4
- CBNumber:
- CB92604353
- Summenformel:
- C18H17F5NO5P
- Molgewicht:
- 453.3
- MOL-Datei:
- 1334513-02-8.mol
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester Eigenschaften
- Schmelzpunkt:
- 133-135°C
- Siedepunkt:
- 442.6±55.0 °C(Predicted)
- Dichte
- 1.405
- Dampfdruck
- 0Pa at 25℃
- storage temp.
- 2-8°C
- L?slichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- -3.81±0.70(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White
- LogP
- 4.1 at 30℃ and pH7.37
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H332 |
Gesundheitssch?dlich bei Einatmen. |
Akute Toxizit?t inhalativ |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P261, P271, P304+P340, P312 |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
| P310 |
Sofort GIFTINFORMATIONSZENTRUM/Arzt/ anrufen. |
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester is a reactant in the synthesis of phosphoramidate imidazo[2,1-f][1,2,4]triazine-4-amine adenosine prodrugs that can increase anti-HCV activity.
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 300)Lieferanten
- 1. (S)-isopropyl2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester (SIDE CHAIN)
- L-Alanine, N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-methylethyl ester
- propan-2-yl (2S)-2-{[(S)-pentafluorophenoxy(phenoxy)phosphoryl]amino}propanoate
- Sofosbuvir side chain N-1
- Sofosbuvir Intermediate 5
- isopropyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
- (S)-isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)aMino)propanoate
- Isopropyl N-[(pentafluorophenoxy)(phenoxy)phosphoryl]-L-alaninate
- Sofosbuvir InterMediates
- (2S)-isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)aMino)propanoate
- SofosBuvir Impurity 15
- 2'-Defluro-2'-hydroxy 2'-epi-Sofosbuvir
- Isopropyl (2S)-2-[[(S)-(Perfluorophenoxy)(phenoxy)phosphoryl]amino]propionate
- Sofosbuvir InterMediates4
- isopropyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanite
- ((2R,3R,4S,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
- Sofosbuvir imp-75
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy) phenoxyphosphatidyl ]- L- alanine isopropyl ester
- N-[(S)-(2,3,4,5, 6-pentafluorophenoxy) phenoxyphosphoacyl] -L-alanine isopropyl ester
- SF-1.2
- propan-2-yl(2S)-2-[[(2,3,4,5,6-pentafluorophenoxy)-phenoxyphosphoryl]amino]propanoate
- Sofosbuvir-003-SS
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester ISO 9001：2015 REACH
- ATP-FTP-phoph
- L-alanien,N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)-phenoxy-phosphinyl]-1-Methylethylester
- 6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
- Isopropyl N-[(pentafluorophenoxy)(phenoxy)phosphoryl]-L-alan...
- (R)-Sofosbuvir Pentafluorophenoxy AnalogueQ: What is
(R)-Sofosbuvir Pentafluorophenoxy Analogue Q: What is the CAS Number of
(R)-Sofosbuvir Pentafluorophenoxy Analogue Q: What is the storage condition of
(R)-Sofosbuvir Pentafluorophenoxy Analogue Q: What are the applications of
(R)-Sofosbuvir Pentafluorophenoxy Analogue
- (R)-Sofosbuvir Pentafluorophenoxy Analogue
- 8 N-[(S)-(2,3,4,5,6 pentafluorophenoxy) phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
- N-[(S)-(2,3,4,5, 6-pentafluorophenoxy) phenoxyphosphoryl] -L-alanine isopropyl ester
- N - [(S) - (2,3,4,5,6-neneneba pentafluorophenyl oxy) phenoxyphosphoryl] - L-alanine isopropyl ester
- Isopropyl N-[(S)-(pentafluorophenoxy)(phenoxy)phosphoryl]-L-alaninate
- Sofibuvir intermediate 1
- N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl este
- (2S)-Isopropyl-2-((perfluorophexyl) (phenoxy)phosphorylamino Propanoate
- N-[ -(2,3,4,5,6-pentafluoro phenoxy)phenoxy phosphinyl]-L-alanine-1-methyl ethyl ester
- 1334513-02-8
- C18H17F5NO5P
- Sofosbuvir intermediate
- Pharmaceuticalintermediates
